Clinuvel Pharmaceuticals (CUV)

Download button icon Download

Clinuvel Pharmaceuticals (CUV): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

No continuation candles currently present.


PROFILE: Clinuvel Pharmaceuticals (CUV.AX)


Stock Exchange: ASX
Company: Clinuvel Pharmaceuticals
Ticker Codes: | CUV.AX | ASX:CUV |

About Clinuvel Pharmaceuticals (ASX:CUV):

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of severe skin disorders. Its lead drug compound is SCENESSE, a medicinal photoprotective and repigmentation drug that has completed Phase II and III trials in the United States and Europe, which is used for the prevention of phototoxicity in adults with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue that acts as a potent skin protectant; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. It has operations in Europe, the United States, and Singapore. The company is headquartered in Melbourne, Australia.

Top 10:

Continuation Candlestick

Download button icon Download
Company Close Change (%) Volume Value Signal
EMH European Metals Holdings 0.4 12.9 50,755 0 NEUTRAL
ISX Isignthis 0.18 9.4 204,166 0 NEUTRAL
LVH Livehire 0.61 8.9 192,832 0 NEUTRAL
RMS Ramelius Resources 0.5 7.5 3,500,339 0 NEUTRAL
DCG Decmil 0.8 6.7 282,536 0 NEUTRAL
BOC Bougainville Copper 0.17 6.3 61,005 0 NEUTRAL
RND Rand Mining 4.03 6.1 33,780 0 NEUTRAL
TGA Thorn 0.62 6 760,651 0 NEUTRAL
CAB Cabcharge Australia 2.4 5.7 194,554 0 NEUTRAL
CCV Cash Converters International 0.33 4.8 1,818,562 0 NEUTRAL
back to top